We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.1%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
-$227M
(-4.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
802
New
109
Increased
252
Reduced
267
Closed
54
Avg Time Held
1.6
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ventas
VTR
|
+$29.1M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$28.3M |
| 3 |
Ecolab
ECL
|
+$25.4M |
| 4 |
Merck
MRK
|
+$24.7M |
| 5 |
Edwards Lifesciences
EW
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ServiceNow
NOW
|
+$44M |
| 2 |
SBA Communications
SBAC
|
+$43.3M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$42M |
| 4 |
TD Ameritrade Holding Corp
AMTD
|
+$40.5M |
| 5 |
Gilead Sciences
GILD
|
+$39.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.75% |
| 2 | Consumer Discretionary | 15.42% |
| 3 | Technology | 15.27% |
| 4 | Financials | 12.99% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
DELISTED
Annaly Capital Management, Inc. 7.50% Series D Cumulative Redeemable Preferred Stock
NLY.PRD
| $2.15M | 0.04% |
88,110
+2,200
| +3% | +$51.3K |
2013 Q2
11 quarters
|
|
|
177
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.13M | 0.04% |
67,540
-1,374,083
| -95% | -$40.5M |
2015 Q1
4 quarters
|
|
|
SSW.PRD
178
DELISTED
Seaspan Corporation 7.95% Series D Cumulative Redeemable Perpetual Preferred Shares
SSW.PRD
| $2.12M | 0.04% |
85,545
+2,950
| +4% | +$69K |
2013 Q4
9 quarters
|
|
179
ASML
ASML
$637B
| $2.11M | 0.04% |
21,058
-4,554
| -18% | -$411K |
2014 Q1
8 quarters
|
|
180
CHS Inc Class B Preferred Stock
CHSCO
$549M
| $2.09M | 0.04% |
73,105
-4,000
| -5% | -$113K |
2013 Q3
10 quarters
|
|
|
INXN
181
DELISTED
Interxion Holding N.V.
INXN
| $2.08M | 0.04% |
60,290
+11,955
| +25% | +$372K |
2015 Q4
1 quarter
|
|
182
Fastenal
FAST
$57.8B
| $2.05M | 0.04% |
167,496
+548
| +0.3% | +$5.96K |
2013 Q2
11 quarters
|
|
|
ITC
183
DELISTED
ITC HOLDINGS CORP
ITC
| $2.04M | 0.04% |
46,899
-27,466
| -37% | -$1.12M |
2013 Q2
11 quarters
|
|
|
SAQ.CL
184
DELISTED
Saratoga Investment Corp.
SAQ.CL
| $2.03M | 0.04% |
81,115
+1,400
| +2% | +$34.3K |
2013 Q2
11 quarters
|
|
185
Vanguard Real Estate ETF
VNQ
$36.7B
| $2.02M | 0.04% |
24,142
-661
| -3% | -$51.5K |
2014 Q1
8 quarters
|
|
186
Unifirst Corp
UNF
$4.79B
| $1.99M | 0.04% |
18,263
+2,132
| +13% | +$223K |
2013 Q2
11 quarters
|
|
187
DELISTED
Western Gas Partners Lp
WES
| $1.98M | 0.04% |
45,505
+1,295
| +3% | +$47.8K |
2013 Q2
11 quarters
|
|
188
Automatic Data Processing
ADP
$113B
| $1.97M | 0.04% |
21,984
+155
| +0.7% | +$13K |
2013 Q2
11 quarters
|
|
189
Stryker
SYK
$112B
| $1.95M | 0.04% |
18,184
+3,160
| +21% | +$311K |
2013 Q2
11 quarters
|
|
190
InterContinental Hotels
IHG
$24.3B
| $1.94M | 0.04% |
35,702
-3,395
| -9% | -$163K |
2014 Q4
5 quarters
|
|
|
ALXN
191
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.89M | 0.04% |
13,551
-35
| -0.3% | -$5.14K |
2013 Q2
11 quarters
|
|
192
Reinsurance Group of America
RGA
$17.2B
| $1.88M | 0.04% |
19,550
| – | – |
2014 Q1
8 quarters
|
|
|
PSXP
193
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $1.87M | 0.04% |
29,860
+935
| +3% | +$54.4K |
2014 Q1
8 quarters
|
|
194
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
| $1.86M | 0.04% |
17,718
-723
| -4% | -$71.7K |
2014 Q1
8 quarters
|
|
195
Roper Technologies
ROP
$37.8B
| $1.85M | 0.04% |
10,119
+14
| +0.1% | +$2.41K |
2014 Q1
8 quarters
|
|
|
NGHCP
196
DELISTED
National General Holdings Corp Preferred Stock, Series A
NGHCP
| $1.82M | 0.04% |
71,325
+3,600
| +5% | +$91.2K |
2014 Q2
7 quarters
|
|
|
CERN
197
DELISTED
Cerner Corp
CERN
| $1.79M | 0.04% |
33,747
-270
| -0.8% | -$14.7K |
2014 Q1
8 quarters
|
|
198
Caterpillar
CAT
$338B
| $1.77M | 0.04% |
23,155
-1,824
| -7% | -$122K |
2013 Q2
11 quarters
|
|
199
Mondelez International
MDLZ
$80.4B
| $1.77M | 0.04% |
44,073
-279,209
| -86% | -$11.4M |
2013 Q2
11 quarters
|
|
200
VF Corp
VFC
$6.68B
| $1.76M | 0.04% |
28,932
+326
| +1% | +$18.9K |
2014 Q1
8 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Geneva Advisors held 802 positions worth $4.97B, down 4.4% from $5.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Geneva Advisors's Q1 2016 filing shows 109 new, 252 increased, 267 reduced and 54 closed positions. Its largest new stake was Ventas: 517,036 shares worth $32.6M. The largest sale was ServiceNow, an estimated $44M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Technology.
- Geneva Advisors's largest Q1 2016 buy was Ventas: 517,036 shares worth $32.6M.
- Geneva Advisors added most to Bristol-Myers Squibb in Q1 2016, an estimated $28.3M increase.
- Geneva Advisors's biggest Q1 2016 reduction was SBA Communications, cutting an estimated $43.3M.
- Geneva Advisors fully exited ServiceNow in Q1 2016, selling an estimated $44M.
- Geneva Advisors's ten largest holdings make up 25% of its $4.97B portfolio in Q1 2016.
- Geneva Advisors opened 109 new positions and closed 54 in Q1 2016.
- Geneva Advisors's portfolio value fell 4.4% quarter-over-quarter to $4.97B.
Based on Geneva Advisors's 13F filing for Q1 2016, filed 3 May 2016.